BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 26160608)

  • 1. A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB).
    Loprinzi CL; Dueck AC; Khoyratty BS; Barton DL; Jafar S; Rowland KM; Atherton PJ; Marsa GW; Knutson WH; Bearden JD; Kottschade L; Fitch TR
    Ann Oncol; 2009 Mar; 20(3):542-9. PubMed ID: 19129205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis.
    Loprinzi CL; Sloan J; Stearns V; Slack R; Iyengar M; Diekmann B; Kimmick G; Lovato J; Gordon P; Pandya K; Guttuso T; Barton D; Novotny P
    J Clin Oncol; 2009 Jun; 27(17):2831-7. PubMed ID: 19332723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crossover trial of gabapentin and memantine as treatment for acquired nystagmus.
    Thurtell MJ; Joshi AC; Leone AC; Tomsak RL; Kosmorsky GS; Stahl JS; Leigh RJ
    Ann Neurol; 2010 May; 67(5):676-80. PubMed ID: 20437565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen deprivation therapy-associated vasomotor symptoms.
    Jones JM; Kohli M; Loprinzi CL
    Asian J Androl; 2012 Mar; 14(2):193-7. PubMed ID: 22286861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation and Application of Thresholds to Define Meaningful Change in Vasomotor Symptoms Frequency: Analysis of Pooled SKYLIGHT 1 and 2 Data.
    Morga A; Zimmermann L; Valluri U; Siddiqui E; McLeod L; Bender RH
    Adv Ther; 2024 Jul; 41(7):2845-2858. PubMed ID: 38775925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Gabapentin with Estrogen for treatment of hot flashes in post-menopausal women.
    Allameh Z; Rouholamin S; Valaie S
    J Res Pharm Pract; 2013 Apr; 2(2):64-9. PubMed ID: 24991606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electroacupuncture Versus Gabapentin for Hot Flashes Among Breast Cancer Survivors: A Randomized Placebo-Controlled Trial.
    Mao JJ; Bowman MA; Xie SX; Bruner D; DeMichele A; Farrar JT
    J Clin Oncol; 2015 Nov; 33(31):3615-20. PubMed ID: 26304905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy of nonhormonal drugs on menopausal hot flashes.
    Li L; Xu L; Wu J; Dong L; Zhao S; Zheng Q
    Eur J Clin Pharmacol; 2016 Sep; 72(9):1051-8. PubMed ID: 27450233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacological and hormonal therapy of hot flushes in breast cancer survivors.
    Wiśniewska I; Jochymek B; Lenart-Lipińska M; Chabowski M
    Breast Cancer; 2016 Mar; 23(2):178-82. PubMed ID: 26498637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Efficacy and Safety of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in the Treatment of Menopausal Hot Flashes: A Systematic Review of Clinical Trials.
    Azizi M; Khani S; Kamali M; Elyasi F
    Iran J Med Sci; 2022 May; 47(3):173-193. PubMed ID: 35634530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Efficacy and Safety of Clonazepam versus Nortrptilline on Menopausal Symptom among Forty Plus Women: A Prospective, Open-Label Randomized Study.
    Roshi ; Tandon VR; Mahajan A; Sharma S; Khajuria V
    J Midlife Health; 2020; 11(3):120-125. PubMed ID: 33384533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and feasibility of estrogen receptor-β targeted phytoSERM formulation for menopausal symptoms: phase 1b/2a randomized clinical trial.
    Schneider LS; Hernandez G; Zhao L; Franke AA; Chen YL; Pawluczyk S; Mack WJ; Brinton RD
    Menopause; 2019 Aug; 26(8):874-884. PubMed ID: 30889096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steady-state pharmacokinetics of gabapentin after administration of a novel gastroretentive extended-release formulation in postmenopausal women with vasomotor symptoms.
    Cowles VE; Gordi T; Hou SY
    Clin Drug Investig; 2012 Sep; 32(9):593-601. PubMed ID: 22775354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gabapentin for the treatment of menopausal hot flashes: a randomized controlled trial.
    Butt DA; Lock M; Lewis JE; Ross S; Moineddin R
    Menopause; 2008; 15(2):310-8. PubMed ID: 17917611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Inquiry: Which nonhormonal treatments are effective for hot flashes?
    Kelsberg G; Maragh L; Safranek S
    J Fam Pract; 2016 May; 65(5):E1-3. PubMed ID: 27275942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gabapentin for the treatment of hot flashes in women with natural or tamoxifen-induced menopause: a systematic review and meta-analysis.
    Toulis KA; Tzellos T; Kouvelas D; Goulis DG
    Clin Ther; 2009 Feb; 31(2):221-35. PubMed ID: 19302896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating vasomotor symptoms of menopause: the nurse practitioner's perspective.
    Alexander IM; Moore A
    J Am Acad Nurse Pract; 2007 Mar; 19(3):152-63. PubMed ID: 17341283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A crossover study comparing gabapentin and fluoxetine for the treatment of vasomotor symptoms among postmenopausal women.
    Rahmanian M; Mohseni A; Ghorbani R
    Int J Gynaecol Obstet; 2015 Oct; 131(1):87-90. PubMed ID: 26160608
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.